Impact on Reducing the Incidence of Low Serum Calcium by Providing Educational Materials on the Need to Take Daily Supplemental Calcium and Vitamin D to Patients With Paget's Disease Treated With Reclast®
Conditions: Paget's Disease of the Bone; HypocalcemiaIntervention: Drug: ZOL446Sponsors: Novartis; Novartis PharmaceuticalsRecruiting - verified January 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 22, 2008 Category: Research Source Type: clinical trials
Impact on Reducing the Incidence of Low Serum Calcium by Providing Educational Materials on the Need to Take Daily Supplemental Calcium and Vitamin D to Patients With Paget's Disease Treated With Reclast®
Conditions: Paget's Disease of the Bone; HypocalcemiaIntervention: Drug: ZOL446Sponsors: Novartis; Novartis PharmaceuticalsCompleted - verified February 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 22, 2008 Category: Research Source Type: clinical trials
Impact on Reducing the Incidence of Low Serum Calcium by Providing Educational Materials on the Need to Take Daily Supplemental Calcium and Vitamin D to Patients With Paget's Disease Treated With Reclast®
Conditions: Paget's Disease of the Bone; HypocalcemiaIntervention: Drug: ZOL446Sponsors: Novartis; Novartis PharmaceuticalsRecruiting - verified January 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 22, 2008 Category: Research Source Type: clinical trials